Skip to main content
Clinical Trials/CTRI/2023/07/055501
CTRI/2023/07/055501
Not yet recruiting
Phase 3

ltrasound-guided erector spinae plane block using dexmedetomidine as an adjuvant to ropivacaine versus ropivacaine alone analgesia in cardiac surgical patients: a prospective double blind randomized controlled trial - NI

PGIMER0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: I998- Other disorder of circulatory system
Sponsor
PGIMER
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
PGIMER

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria will be adult cardiac surgical patients aged 18 to 65 years undergoing elective cardiac surgery.

Exclusion Criteria

  • Exclusion criteria will be as follows:
  • 1\.Patient refusal
  • 2\.Deranged coagulation profile
  • 3\.Spine deformity
  • 4\.Local skin infection
  • 5\.Baseline HR \<60 BPM
  • 6\.Hepatic or renal insufficiency
  • 7\.Significant left main disease
  • 8\.Severe LV systolic dysfunction (LVEF \<30%)
  • 9\.Patients weighing \<40kg and \>70kg

Outcomes

Primary Outcomes

Not specified

Similar Trials